In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Chlorous acid, sodium salt (1:1) Drug Master File in Korea (Chlorous acid, sodium salt (1:1) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Chlorous acid, sodium salt (1:1). The MFDS reviews the Chlorous acid, sodium salt (1:1) KDMF as part of the drug registration process and uses the information provided in the Chlorous acid, sodium salt (1:1) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Chlorous acid, sodium salt (1:1) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Chlorous acid, sodium salt (1:1) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Chlorous acid, sodium salt (1:1) suppliers with KDMF on PharmaCompass.